Soto A, Sonnenschein C
Environ Health Perspect. 2024; 132(2):21304.
PMID: 38415614
PMC: 10901106.
DOI: 10.1289/EHP14499.
Artzy-Randrup Y, Epstein T, Brown J, Costa R, Czerniecki B, Gatenby R
NPJ Breast Cancer. 2021; 7(1):26.
PMID: 33707440
PMC: 7952601.
DOI: 10.1038/s41523-021-00230-y.
Soto A, Schaeberle C, Sonnenschein C
Nat Rev Endocrinol. 2021; 17(4):247-256.
PMID: 33514909
PMC: 9662687.
DOI: 10.1038/s41574-020-00460-3.
Horwitz K, Sartorius C
J Mol Endocrinol. 2020; 65(1):T49-T63.
PMID: 32485679
PMC: 8525510.
DOI: 10.1530/JME-20-0104.
Gandhi N, Das G
Cells. 2019; 8(2.
PMID: 30691108
PMC: 6406734.
DOI: 10.3390/cells8020089.
Good Guy or Bad Guy? The Duality of Wild-Type p53 in Hormone-Dependent Breast Cancer Origin, Treatment, and Recurrence.
McGowan E, Lin Y, Hatoum D
Cancers (Basel). 2018; 10(6).
PMID: 29857525
PMC: 6025368.
DOI: 10.3390/cancers10060172.
Steroid hormones, steroid receptors, and breast cancer stem cells.
Finlay-Schultz J, Sartorius C
J Mammary Gland Biol Neoplasia. 2015; 20(1-2):39-50.
PMID: 26265122
PMC: 4666507.
DOI: 10.1007/s10911-015-9340-5.
The p53-estrogen receptor loop in cancer.
Berger C, Qian Y, Chen X
Curr Mol Med. 2013; 13(8):1229-40.
PMID: 23865427
PMC: 3780397.
DOI: 10.2174/15665240113139990065.
Exposures to synthetic estrogens at different times during the life, and their effect on breast cancer risk.
Hilakivi-Clarke L, de Assis S, Warri A
J Mammary Gland Biol Neoplasia. 2013; 18(1):25-42.
PMID: 23392570
PMC: 3635108.
DOI: 10.1007/s10911-013-9274-8.
Progesterone-inducible cytokeratin 5-positive cells in luminal breast cancer exhibit progenitor properties.
Axlund S, Yoo B, Rosen R, Schaack J, Kabos P, LaBarbera D
Horm Cancer. 2012; 4(1):36-49.
PMID: 23184698
PMC: 3549640.
DOI: 10.1007/s12672-012-0127-5.
Effects of omega-3 fatty acids on progestin stimulation of invasive properties in breast cancer.
Moore M, King R
Horm Cancer. 2012; 3(5-6):205-17.
PMID: 22833172
PMC: 10358024.
DOI: 10.1007/s12672-012-0118-6.
Progesterone regulation of stem and progenitor cells in normal and malignant breast.
Axlund S, Sartorius C
Mol Cell Endocrinol. 2011; 357(1-2):71-9.
PMID: 21945473
PMC: 3288619.
DOI: 10.1016/j.mce.2011.09.021.
Effects of short-term estrogen treatment on the progression of N-methyl-N-nitrosourea-induced premalignant mammary lesions in female Lewis rats.
Yuri T, Lai Y, Kanematsu S, Kuwata M, Yoshizawa K, Tsubura A
Med Mol Morphol. 2011; 44(3):125-30.
PMID: 21922383
DOI: 10.1007/s00795-010-0515-2.
Decreasing hormonal promotion is key to breast cancer prevention.
Rajkumar L, Canada A, Esparza D, Collins K, Moreno E, Duong H
Endocrine. 2009; 35(2):220-6.
PMID: 19214806
DOI: 10.1007/s12020-009-9155-5.
Quantitation of steroid hormones in thin fresh frozen tissue sections.
Blonder J, Johann D, Veenstra T, Xiao Z, Emmert-Buck M, Ziegler R
Anal Chem. 2008; 80(22):8845-52.
PMID: 18937426
PMC: 7236062.
DOI: 10.1021/ac801402a.
Both ovarian hormones estrogen and progesterone are necessary for hormonal mammary carcinogenesis in ovariectomized ACI rats.
Blank E, Wong P, Lakshmanaswamy R, Guzman R, Nandi S
Proc Natl Acad Sci U S A. 2008; 105(9):3527-32.
PMID: 18299580
PMC: 2265202.
DOI: 10.1073/pnas.0710535105.
Hormones and breast cancer: controlling the danger within.
J Exp Med. 2007; 204(4):699.
PMID: 17523238
PMC: 2118558.
DOI: 10.1084/jem.2044fta.
Hormone-induced protection of mammary tumorigenesis in genetically engineered mouse models.
Rajkumar L, Kittrell F, Guzman R, Brown P, Nandi S, Medina D
Breast Cancer Res. 2007; 9(1):R12.
PMID: 17257424
PMC: 1851398.
DOI: 10.1186/bcr1645.
Pregnancy and stem cell behavior.
Wagner K, Smith G
J Mammary Gland Biol Neoplasia. 2005; 10(1):25-36.
PMID: 15886884
DOI: 10.1007/s10911-005-2538-1.
Insulin-like growth factor (IGF)-I obliterates the pregnancy-associated protection against mammary carcinogenesis in rats: evidence that IGF-I enhances cancer progression through estrogen receptor-alpha activation via the mitogen-activated protein....
Thordarson G, Slusher N, Leong H, Ochoa D, Rajkumar L, Guzman R
Breast Cancer Res. 2004; 6(4):R423-36.
PMID: 15217511
PMC: 468665.
DOI: 10.1186/bcr812.
